Groupama Asset Managment Decreases Position in Colgate-Palmolive Company $CL

Key Points

• Groupama Asset Management has reduced its stake in Colgate-Palmolive Company by 63.6%, selling 20,191 shares and now holding 11,576 shares valued at approximately $1,074,000.
• Several institutional investors have increased their holdings in Colgate-Palmolive, with Goldman Sachs boosting its position by 34.5% to own nearly 8 million shares worth around $747.76 million.
• Colgate-Palmolive recently announced a quarterly dividend of $0.52 per share, which represents an annualized dividend yield of 2.4% and a payout ratio of 58.43%.

Groupama Asset Managment reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 63.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,576 shares of the company's stock after selling 20,191 shares during the quarter. Groupama Asset Managment's holdings in Colgate-Palmolive were worth $1,074,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Westend Capital Management LLC increased its stake in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in shares of Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $31,000. Accredited Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $34,000. Finally, Bernard Wealth Management Corp. bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $36,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 0.6%

Shares of NYSE CL traded down $0.5010 during trading hours on Friday, reaching $85.7790. The stock had a trading volume of 4,087,413 shares, compared to its average volume of 5,056,872. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The firm has a market cap of $69.33 billion, a price-to-earnings ratio of 24.10, a P/E/G ratio of 4.47 and a beta of 0.35. The business's fifty day moving average price is $87.60 and its two-hundred day moving average price is $89.93. Colgate-Palmolive Company has a 52-week low of $82.40 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.43%.

Analyst Upgrades and Downgrades

CL has been the topic of a number of analyst reports. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Citigroup cut their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Morgan Stanley cut their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, UBS Group lowered their price target on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.